A recent study suggests that individuals who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who end conventional lifestyle programs.
Research printed in a major health publication shows that while overweight individuals often shed about a fifth of their body weight while using the jabs, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"Users using such treatments must be aware of the danger of rapid weight regain when the treatment is stopped," stated expert Dr. Susan Jebb.
That rate of recovery implies a return to pre-treatment weight within about 18 months.
Analyzing Approaches
The research, which examined dozens of trials involving over 9,000 of patients, compared the outcomes of GLP-1 agonists with older methods.
Scientists point out that people who shed pounds through lifestyle changes alone usually have a slower creep back—approximately 0.1 kg a month—once they finish.
Understanding the Rapid Regain
Nutrition scientists propose the mode of action of the drugs accounts for the accelerated weight return.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.
"Artificially providing the hormone levels far above than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this GLP-1 'fix' means appetite is uncontrolled, making overeating a significant risk."
An Ongoing Disease?
Medical guidelines suggest the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Many experts argue that, considering the likelihood of relapse, the therapy might need to be life-long.
This view is supported by drug manufacturers, who note that the results "underscore the persistent nature of excess weight," akin to managing diseases like hypertension.
User Accounts
People who have come off the jabs explain a intense resurgence of hunger.
"It felt as if a switch activating and you become extremely hungry," described one woman.
The struggle is worsened if users have not established lasting lifestyle or habit modifications during treatment.
Growing Adoption
Figures show that millions of adults in the UK have used these injections in the past year, with interest remaining high.
- Use is higher among females than males.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
Ultimately, experts stress that while GLP-1 drugs are effective agents for weight loss, they are not a permanent solution and long-term success likely depends on integrated behavioural management.